Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00869076
NCT00869076
Completed
Phase 4

Pharmacist Management of Diabetes Mellitus: A Randomized Controlled Trial.

Advantage Health Physician Network1 site in 1 country102 target enrollmentMay 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetes Mellitus

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Advantage Health Physician Network
Enrollment
102
Locations
1
Primary Endpoint
Hgb A1c change
Status
Completed
Last Updated
17 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The hypothesis is that patients with poorly controlled diabetes would have greater improvement in their blood sugar control when managed by a clinical pharmacist than when managed with usual medical care. Patients with poor control are randomized to pharmacist management or to usual medical care for one year.

Registry
clinicaltrials.gov
Start Date
May 2006
End Date
December 2007
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Advantage Health Physician Network

Eligibility Criteria

Inclusion Criteria

  • •Age 18 years or older
  • •A1c greater than or equal to 9.0

Exclusion Criteria

  • •Not expected to live for the duration of the study
  • •Managed by an endocrinologist
  • •Unwillingness to participate and attend pharmacist visits

Outcomes

Primary Outcomes

Hgb A1c change

Time Frame: 1 year

Secondary Outcomes

  • percent of patients with a 1 point or greater decrease in A1c(one year)
  • HgbA1c change based on ethnicity(one year)
  • Percent of patients with a 1 point decrease in A1c by ethnicity(one year)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RTDiabetes Mellitus
NCT00111228Medtronic Diabetes162
Completed
Not Applicable
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.Type 2 Diabetes Mellitus
NCT00747383The Royal Bournemouth Hospital74
Completed
Not Applicable
Use of Midlevel Providers in Diabetes ManagementDiabetes Mellitus
NCT00237094National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)600
Completed
Not Applicable
The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in JordanPharmacist-Patient Relations
NCT06029842University of Jordan103
Completed
Not Applicable
Impact of Pharmaceutical Care in Diabetics PatientsDiabetes Mellitus Type 2
NCT01580904Universidade Estadual da Paraiba100